As a healthcare provider who works with low vision patients, you have a clear understanding of the impact that visual impairment can have on their mental health, quality of life and ability to live independently.
With eSight, thousands of individuals have gained or regained access to the interests, livelihoods and Activities of Daily Living (ADLs) which allow them to enjoy full and active lives. For patients in your care, eSight may be a far more effective option than any other device, procedure, or treatment.
eSight is a Class I Medical Device registered with the FDA and EUDAMED, and inspected by Health Canada. It displays real-time footage to the user via a high-speed, high-resolution 21.5 MP camera and projects it onto two OLED screens in front of the eyes. A handheld trackpad allows user control of color, contrast, focus, brightness and magnification, and prescription lenses can be crafted and installed directly into the unit.
eSight is currently worn by individuals managing a wide variety of common conditions, including Macular Degeneration, Diabetic Retinopathy, Ocular Albinism, Optic Atrophy, Glaucoma, and many more.
A six-site clinical study entitled the “eSight Quality of Life and Efficacy Study (eQUEST)” was completed in early 2017.
The study provided validation of eSight’s efficacy for those with low vision. It showed significant improvement in multiple objective visual function measures, the ability to perform Activities of Daily Living (ADLs), and direct patient reports of eSight improving their quality of life, as measured by the well-validated “VA LV VFQ-48” questionnaire.
The eQUEST study was led by researchers from the six preeminent low vision research and rehabilitation institutions listed below.
Interested in the potential that eSight could offer for your patients? Submit your practice information to receive more information about the eSight Clinical Consultation Program.